- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Ken Cohen Speaks on the Impact of Market Power on Biosimilar Uptake
Ken Cohen, MD, director of translational research for Optum Care, speaks on the future of more biosimilars hitting the market, and how they will influence value-based care.
Ken Cohen, MD, director of translational research for Optum Care, speaks on the future of more biosimilars hitting the market, and how they will influence value-based care.
Transcript
As more and more biosimilars are hitting the market, how is the approach to biosimilars changing? And how will the approach of prescribing a biologic versus a biosimilar change?
Being able to differentiate between biosimilars won't be possible, because large [randomized controlled trials] for each of those biosimilars have not been done in head-to-head comparative fashion. There is recognition that the clinical efficacy of those is equivalent and, therefore, it will come back to market powers in terms of cost and availability.
There will be gaming of the system where the branded agents will try to leverage formulary placement with access to their other drugs and other things that pharma has done over the years to try to protect branded agents. I think in a value-based world, you make the best decision based on the individual cost effectiveness of a single product. Over time, I think that will create the landscape where biosimilars can gain footing and ultimately decrease cost of care for patients.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
